TreeWAS – Variant ID: rs2268983

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K74.3 Primary biliary cirrhosis	0.024	0.976	0.000
F25 Schizoaffective disorders	0.020	0.980	0.000
F25.1 Schizoaffective disorder, depressive type	0.019	0.981	0.000
F25.9 Schizoaffective disorder, unspecified	0.019	0.981	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.018	0.982	0.000
F20.9 Schizophrenia, unspecified	0.017	0.983	0.000
F22 Persistent delusional disorders	0.017	0.983	0.000
F22.0 Delusional disorder	0.017	0.983	0.000
F20 Schizophrenia	0.017	0.983	0.000
F25.0 Schizoaffective disorder, manic type	0.017	0.983	0.000
F23 Acute and transient psychotic disorders	0.015	0.985	0.000
F25.2 Schizoaffective disorder, mixed type	0.015	0.985	0.000
F25.8 Other schizoaffective disorders	0.015	0.985	0.000
F20.2 Catatonic schizophrenia	0.014	0.986	0.000
F21 Schizotypal disorder	0.013	0.987	0.000
K74 Fibrosis and cirrhosis of liver	0.013	0.987	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.013	0.987	0.000
H40.8 Other glaucoma	0.000	0.987	0.013
F28 Other nonorganic psychotic disorders	0.013	0.987	0.000
F24 Induced delusional disorder	0.013	0.987	0.000
F22.8 Other persistent delusional disorders	0.012	0.988	0.000
F20.6 Simple schizophrenia	0.012	0.988	0.000
F20.4 Postschizophrenic depression	0.012	0.988	0.000
F20.3 Undifferentiated schizophrenia	0.012	0.988	0.000
F20.1 Hebephrenic schizophrenia	0.012	0.988	0.000
K74.5 Biliary cirrhosis, unspecified	0.012	0.988	0.000
F20.0 Paranoid schizophrenia	0.012	0.988	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.012	0.988	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.011	0.989	0.000
F20.8 Other schizophrenia	0.011	0.989	0.000
F22.9 Persistent delusional disorder, unspecified	0.011	0.989	0.000
F23.8 Other acute and transient psychotic disorders	0.011	0.989	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.011	0.989	0.000
I12.9 Hypertensive renal disease without renal failure	0.011	0.989	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.011	0.989	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.010	0.989	0.000
K76.9 Liver disease, unspecified	0.011	0.989	0.000
F20.5 Residual schizophrenia	0.010	0.990	0.000
K74.4 Secondary biliary cirrhosis	0.010	0.990	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.010	0.990	0.000
K76 Other diseases of liver	0.010	0.990	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.991	0.009
K74.1 Hepatic sclerosis	0.009	0.991	0.000
K74.0 Hepatic fibrosis	0.009	0.991	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.009	0.991	0.000
K73 Chronic hepatitis, not elsewhere classified	0.008	0.992	0.000
H40.0 Glaucoma suspect	0.000	0.992	0.008
K70-K77 Diseases of liver	0.008	0.992	0.000
H40.5 Glaucoma secondary to other eye disorders	0.000	0.992	0.008
K76.7 Hepatorenal syndrome	0.008	0.992	0.000
O36.5 Maternal care for poor foetal growth	0.000	0.992	0.008
H40 Glaucoma	0.000	0.992	0.008
F29 Unspecified nonorganic psychosis	0.007	0.992	0.000
Y60.0 During surgical operation	0.007	0.993	0.000
K76.5 Hepatic veno-occlusive disease	0.007	0.993	0.000
K76.4 Peliosis hepatis	0.007	0.993	0.000
K76.3 Infarction of liver	0.007	0.993	0.000
K76.2 Central haemorrhagic necrosis of liver	0.007	0.993	0.000
K73.9 Chronic hepatitis, unspecified	0.007	0.993	0.000
M41.86 Other forms of scoliosis (Lumbar region)	0.006	0.993	0.000
M41.9 Scoliosis, unspecified	0.006	0.994	0.000
M41.8 Other forms of scoliosis	0.006	0.994	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.006	0.994	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.006	0.994	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.006	0.994	0.000
H40.3 Glaucoma secondary to eye trauma	0.000	0.994	0.006
M41 Scoliosis	0.006	0.994	0.000
K71 Toxic liver disease	0.006	0.994	0.000
H40.6 Glaucoma secondary to drugs	0.000	0.994	0.006
K77 Liver disorders in diseases classified elsewhere	0.006	0.994	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.006	0.994	0.000
K76.1 Chronic passive congestion of liver	0.005	0.994	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.006	0.994	0.000
M41.5 Other secondary scoliosis	0.005	0.995	0.000
H40.4 Glaucoma secondary to eye inflammation	0.000	0.995	0.005
M41.92 Scoliosis, unspecified (Cervical region)	0.005	0.995	0.000
C92.0 Acute myeloid leukaemia	0.000	0.995	0.005
M41.96 Scoliosis, unspecified (Lumbar region)	0.005	0.995	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.005	0.995	0.000
K76.6 Portal hypertension	0.005	0.995	0.000
M41.85 Other forms of scoliosis (Thoracolumbar region)	0.005	0.995	0.000
K86.1 Other chronic pancreatitis	0.000	0.995	0.005
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.005
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.005	0.995	0.000
T42.1 Iminostilbenes	0.005	0.995	0.000
M41.56 Other secondary scoliosis (Lumbar region)	0.005	0.995	0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.005	0.995	0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.005	0.995	0.000
M41.54 Other secondary scoliosis (Thoracic region)	0.005	0.995	0.000
M41.89 Other forms of scoliosis (Site unspecified)	0.005	0.995	0.000
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M41.87 Other forms of scoliosis (Lumbosacral region)	0.005	0.995	0.000
M41.84 Other forms of scoliosis (Thoracic region)	0.005	0.995	0.000
M41.83 Other forms of scoliosis (Cervicothoracic region)	0.005	0.995	0.000
M41.82 Other forms of scoliosis (Cervical region)	0.005	0.995	0.000
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)	0.005	0.995	0.000
M41.80 Other forms of scoliosis (Multiple sites in spine)	0.005	0.995	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.005	0.995	0.000
K74.6 Other and unspecified cirrhosis of liver	0.005	0.995	0.000
K71.9 Toxic liver disease, unspecified	0.004	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
K71.0 Toxic liver disease with cholestasis	0.004	0.995	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.004	0.995	0.000
M41.4 Neuromuscular scoliosis	0.004	0.996	0.000
M41.3 Thoracogenic scoliosis	0.004	0.996	0.000
M41.2 Other idiopathic scoliosis	0.004	0.996	0.000
M41.1 Juvenile idiopathic scoliosis	0.004	0.996	0.000
M41.0 Infantile idiopathic scoliosis	0.004	0.996	0.000
K71.8 Toxic liver disease with other disorders of liver	0.004	0.996	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.004	0.996	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.004	0.996	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.004	0.996	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.004	0.996	0.000
K71.2 Toxic liver disease with acute hepatitis	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
M41.59 Other secondary scoliosis (Site unspecified)	0.004	0.996	0.000
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M41.57 Other secondary scoliosis (Lumbosacral region)	0.004	0.996	0.000
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.004	0.996	0.000
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.004	0.996	0.000
M41.52 Other secondary scoliosis (Cervical region)	0.004	0.996	0.000
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.004	0.996	0.000
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.004	0.996	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.004	0.996	0.000
S02.4 Fracture of malar and maxillary bones	0.000	0.996	0.004
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.003	0.996	0.000
H60.1 Cellulitis of external ear	0.004	0.996	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.004	0.996	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.004	0.996	0.000
T42.3 Barbiturates	0.003	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.996	0.000
X62.9 Unspecified place	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.996	0.000
K72 Hepatic failure, not elsewhere classified	0.003	0.996	0.000
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.003	0.997	0.000
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.003	0.997	0.000
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.003	0.997	0.000
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.003	0.997	0.000
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.003	0.997	0.000
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.003	0.997	0.000
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.003	0.997	0.000
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.003	0.997	0.000
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.003	0.997	0.000
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.003	0.997	0.000
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.003	0.997	0.000
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.003	0.997	0.000
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.003	0.997	0.000
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.003	0.997	0.000
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.003	0.997	0.000
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.003	0.997	0.000
M41.29 Other idiopathic scoliosis (Site unspecified)	0.003	0.997	0.000
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.003	0.997	0.000
M41.26 Other idiopathic scoliosis (Lumbar region)	0.003	0.997	0.000
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.003	0.997	0.000
M41.24 Other idiopathic scoliosis (Thoracic region)	0.003	0.997	0.000
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.003	0.997	0.000
M41.22 Other idiopathic scoliosis (Cervical region)	0.003	0.997	0.000
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.003	0.997	0.000
M41.39 Thoracogenic scoliosis-Site unspe	0.003	0.997	0.000
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.003	0.997	0.000
M41.37 Thoracogenic scoliosis-Lumbosacral	0.003	0.997	0.000
M41.36 Thoracogenic scoliosis-Lumbar	0.003	0.997	0.000
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.003	0.997	0.000
M41.34 Thoracogenic scoliosis (Thoracic region)	0.003	0.997	0.000
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.003	0.997	0.000
M41.32 Thoracogenic scoliosis-Cervical	0.003	0.997	0.000
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.003	0.997	0.000
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.003	0.997	0.000
M41.49 Neuromuscular scoliosis (Site unspecified)	0.003	0.997	0.000
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.003	0.997	0.000
M41.46 Neuromuscular scoliosis (Lumbar region)	0.003	0.997	0.000
M41.45 Neuromuscular scoliosis (Thoracolumbar region)	0.003	0.997	0.000
M41.44 Neuromuscular scoliosis (Thoracic region)	0.003	0.997	0.000
M41.43 Neuromuscular scoliosis (Cervicothoracic region)	0.003	0.997	0.000
M41.42 Neuromuscular scoliosis (Cervical region)	0.003	0.997	0.000
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
M41.40 Neuromuscular scoliosis (Multiple sites in spine)	0.003	0.997	0.000
W25.9 Unspecified place	0.003	0.997	0.000
H60.5 Acute otitis externa, non-infective	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
H60 Otitis externa	0.003	0.997	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
C92 Myeloid leukaemia	0.000	0.997	0.003
H60.9 Otitis externa, unspecified	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
H40-H42 Glaucoma	0.000	0.997	0.003
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.997	0.003
H60.4 Cholesteatoma of external ear	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.003	0.997	0.000
H40.2 Primary angle-closure glaucoma	0.000	0.997	0.003
C92.7 Other myeloid leukaemia	0.000	0.997	0.003
I70.00 Atherosclerosis of aorta (without gangrene)	0.003	0.997	0.000
K60.3 Anal fistula	0.003	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
K72.0 Acute and subacute hepatic failure	0.003	0.997	0.000
I12 Hypertensive renal disease	0.003	0.997	0.000
K75 Other inflammatory liver diseases	0.003	0.997	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.997	0.003
K51.5 Mucosal proctocolitis	0.000	0.997	0.003
H40.1 Primary open-angle glaucoma	0.000	0.997	0.003
H60.8 Other otitis externa	0.003	0.997	0.000
H60.2 Malignant otitis externa	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.000	0.997	0.003
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.003	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.997	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.997	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.997	0.002
C92.3 Myeloid sarcoma	0.000	0.997	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.997	0.002
H42 Glaucoma in diseases classified elsewhere	0.000	0.997	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
H60.0 Abscess of external ear	0.002	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
N48.0 Leukoplakia of penis	0.003	0.997	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.003	0.997	0.000
D06.9 Cervix, unspecified	0.000	0.997	0.002
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
K72.1 Chronic hepatic failure	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
X62.8 Other specified place	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
A87.9 Viral meningitis, unspecified	0.000	0.998	0.002
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
K75.2 Nonspecific reactive hepatitis	0.002	0.998	0.000
K75.1 Phlebitis of portal vein	0.002	0.998	0.000
K76.8 Other specified diseases of liver	0.002	0.998	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.002	0.998	0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.002	0.998	0.000
X60.8 Other specified place	0.002	0.998	0.000
X62.0 Home	0.002	0.998	0.000
X62.7 Farm	0.002	0.998	0.000
X62.6 Industrial and construction area	0.002	0.998	0.000
X62.5 Trade and service area	0.002	0.998	0.000
X62.4 Street and highway	0.002	0.998	0.000
X62.3 Sports and athletics area	0.002	0.998	0.000
X62.2 School, other institution and public administrative area	0.002	0.998	0.000
X62.1 Residential institution	0.002	0.998	0.000
H60.3 Other infective otitis externa	0.002	0.998	0.000
N64.8 Other specified disorders of breast	0.002	0.998	0.000
Z74.8 Other problems related to care-provider dependency	0.000	0.998	0.002
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.998	0.002
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.002	0.998	0.000
Y60.9 During unspecified surgical and medical care	0.002	0.998	0.000
Y60.7 During administration of enema	0.002	0.998	0.000
Y60.3 During injection or immunisation	0.002	0.998	0.000
Y60.2 During kidney dialysis or other perfusion	0.002	0.998	0.000
Y60.1 During infusion or transfusion	0.002	0.998	0.000
C44.4 Skin of scalp and neck	0.000	0.998	0.002
Z43.3 Attention to colostomy	0.002	0.998	0.000
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.998	0.002
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.998	0.002
S06.00 Concussion (without open intracranial wound)	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
D76.3 Other histiocytosis syndromes	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.002	0.998	0.000
R07.0 Pain in throat	0.002	0.998	0.000
O35 Maternal care for known or suspected foetal abnormality and damage	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
M46.46 Discitis, unspecified (Lumbar region)	0.002	0.998	0.000
H61.2 Impacted cerumen	0.000	0.998	0.002
K75.0 Abscess of liver	0.002	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.002	0.998	0.000
N04.9 Unspecified	0.002	0.998	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.002	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.002	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.998	0.002
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
Y60.8 During other surgical and medical care	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.998	0.002
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.998	0.002
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.998	0.002
C84.3 Lymphoepithelioid lymphoma	0.000	0.998	0.002
C84.2 T-zone lymphoma	0.000	0.998	0.002
C84.1 Sezary's diease	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
Z31.4 Procreative investigation and testing	0.000	0.998	0.002
X60-X84 Intentional self-harm	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
Y60.5 During heart catheterisation	0.002	0.998	0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.002	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.002	0.998	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.998	0.002
S42.00 Fracture of clavicle (closed)	0.002	0.998	0.000
K60.2 Anal fissure, unspecified	0.002	0.998	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.002	0.998	0.000
G83.8 Other specified paralytic syndromes	0.000	0.998	0.002
S50.9 Superficial injury of forearm, unspecified	0.000	0.998	0.002
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
Q21.0 Ventricular septal defect	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
Y60.4 During endoscopic examination	0.002	0.998	0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.002	0.998	0.000
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.002	0.998	0.000
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.002	0.998	0.000
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.002	0.998	0.000
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.002	0.998	0.000
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
X67.9 Unspecified place	0.002	0.998	0.000
B37.3 Candidiasis of vulva and vagina	0.000	0.998	0.002
K60.4 Rectal fistula	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000
X60.6 Industrial and construction area	0.002	0.998	0.000
X60.4 Street and highway	0.002	0.998	0.000
X60.3 Sports and athletics area	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
M25.84 Other specified joint disorders (Hand)	0.000	0.998	0.002
T40.3 Methadone	0.002	0.998	0.000
M95.0 Acquired deformity of nose	0.002	0.998	0.000
W10.8 Other specified place	0.000	0.998	0.002
Z74.1 Need for assistance with personal care	0.000	0.998	0.002
W25 Contact with sharp glass	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
Q21.3 Tetralogy of Fallot	0.002	0.998	0.000
T86.8 Failure and rejection of other transplanted organs and tissues	0.000	0.998	0.002
X61.2 School, other institution and public administrative area	0.002	0.998	0.000
Z31.2 In vitro fertilisation	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.001
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
O14.9 Preeclampsia, unspecified	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
X70.0 Home	0.001	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.998	0.000
X79 Intentional self-harm by blunt object	0.001	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.998	0.000
X75 Intentional self-harm by explosive material	0.001	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.001	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.001	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.001	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.001	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.998	0.002
C67.6 Ureteric orifice	0.002	0.998	0.000
I70.0 Atherosclerosis of aorta	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
K60 Fissure and fistula of anal and rectal regions	0.002	0.998	0.000
X67.0 Home	0.001	0.998	0.000
X69.9 Unspecified place	0.001	0.998	0.000
Z31 Procreative management	0.000	0.998	0.002
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
N93.0 Postcoital and contact bleeding	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.001	0.998	0.000
X61.4 Street and highway	0.001	0.998	0.000
X67.8 Other specified place	0.001	0.998	0.000
X67.7 Farm	0.001	0.998	0.000
X67.6 Industrial and construction area	0.001	0.998	0.000
X67.5 Trade and service area	0.001	0.998	0.000
X67.4 Street and highway	0.001	0.998	0.000
X67.3 Sports and athletics area	0.001	0.998	0.000
X67.2 School, other institution and public administrative area	0.001	0.998	0.000
X67.1 Residential institution	0.001	0.998	0.000
Z31.9 Procreative management, unspecified	0.000	0.998	0.002
Z31.3 Other assisted fertilisation methods	0.000	0.998	0.002
O21.0 Mild hyperemesis gravidarum	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.001
S12.70 Multiple fractures of cervical spine (closed)	0.002	0.998	0.000
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.998	0.002
G83.1 Monoplegia of lower limb	0.000	0.998	0.002
Q21.8 Other congenital malformations of cardiac septa	0.001	0.998	0.000
X61.9 Unspecified place	0.001	0.998	0.000
X61.8 Other specified place	0.001	0.998	0.000
X61.0 Home	0.001	0.998	0.000
X61.7 Farm	0.001	0.998	0.000
X61.6 Industrial and construction area	0.001	0.998	0.000
X61.5 Trade and service area	0.001	0.998	0.000
X61.3 Sports and athletics area	0.001	0.998	0.000
X61.1 Residential institution	0.001	0.998	0.000
X69.8 Other specified place	0.001	0.998	0.000
X69.7 Farm	0.001	0.998	0.000
X69.6 Industrial and construction area	0.001	0.998	0.000
X69.5 Trade and service area	0.001	0.998	0.000
X69.4 Street and highway	0.001	0.998	0.000
X69.3 Sports and athletics area	0.001	0.998	0.000
X69.2 School, other institution and public administrative area	0.001	0.998	0.000
X69.1 Residential institution	0.001	0.998	0.000
X84 Intentional self-harm by unspecified means	0.001	0.998	0.000
H53.8 Other visual disturbances	0.002	0.998	0.000
N70.1 Chronic salpingitis and oophoritis	0.002	0.998	0.000
W25.8 Other specified place	0.001	0.998	0.000
X60.09 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics; Home; During unspecified activity	0.001	0.998	0.000
X60.08 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Home , While engaged in other specified activities	0.001	0.998	0.000
X60.99 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Unspecified place, During unspecified activity	0.001	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.998	0.000
T48.4 Expectorants	0.001	0.998	0.000
T48.3 Antitussives	0.001	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.001	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.998	0.000
T48.0 Oxytocic drugs	0.001	0.998	0.000
X70.8 Other specified place	0.001	0.998	0.000
X70.9 Unspecified place	0.001	0.998	0.000
X70.7 Farm	0.001	0.998	0.000
X70.6 Industrial and construction area	0.001	0.998	0.000
X70.5 Trade and service area	0.001	0.998	0.000
X70.4 Street and highway	0.001	0.998	0.000
X70.3 Sports and athletics area	0.001	0.998	0.000
X70.2 School, other institution and public administrative area	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations